Inhibition of urokinase-type plasminogen activator or matrix metalloproteinases prevents cardiac injury and dysfunction during viral myocarditis.

  • Stephane Heymans
  • , Matthias Pauschinger (Co-author)
  • , Armando De Palma
  • , Angela Kallwellis-Opara
  • , Susanne Rutschow
  • , Melissa Swinnen
  • , Davy Vanhoutte
  • , Fangye Gao
  • , Raimund Torpai
  • , Andrew H Baker
  • , Elisabeth Padalko
  • , Johan Neyts
  • , Heinz-Peter Schultheiss
  • , Frans Van de Werf
  • , Peter Carmeliet
  • , Yigal M Pinto

    Research output: Contribution to journalOriginal Articlepeer-review

    88 Citations (Web of Science)
    Original languageEnglish
    Pages (from-to)565-573
    JournalCIRCULATION
    Volume114
    Issue number6
    DOIs
    Publication statusPublished - 2006

    Keywords

    • HEART-DISEASE
    • MURINE MYOCARDITIS
    • TARGETED DELETION
    • IMMUNE-RESPONSE
    • TENASCIN-C
    • GROUP-B
    • MICE
    • CARDIOMYOPATHY
    • INFLAMMATION
    • ASSOCIATION

    Cite this